We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+43.62%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.11B
AUM Growth
+$749M
Cap. Flow
+$251M
Cap. Flow %
11.86%
Top 10 Hldgs %
48.72%
Holding
236
New
91
Increased
31
Reduced
17
Closed
27

Top Sells

Rank Stock Value
1
CDLX icon
Cardlytics
CDLX
+$36.3M
2
PCG icon
PG&E
PCG
+$26M
3
PPLI
People Inc
PPLI
+$17.9M
4
CVNA icon
Carvana
CVNA
+$17.1M
5
ONDK
On Deck Capital, Inc.
ONDK
+$9.27M

Sector Composition

Rank Sector Weight
1 Healthcare 16.24%
2 Consumer Discretionary 12.53%
3 Communication Services 9.65%
4 Financials 9.07%
5 Utilities 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNT icon
51
Vontier
VNT
$4.73B
$8.31M 0.39%
+248,716
New +$7.68M
WGS icon
52
GeneDx Holdings
WGS
$2.08B
$8.28M 0.39%
+22,727
New +$7.92M
FENC icon
53
Fennec Pharmaceuticals
FENC
$365M
$8.27M 0.39%
1,110,000
CMPR icon
54
Cimpress
CMPR
$2.44B
$7.68M 0.36%
87,536
+100
+0.1% +$8.59K
NUVB icon
55
Nuvation Bio
NUVB
$2.22B
$7.64M 0.36%
653,300
+53,300
+9% +$554K
VTR icon
56
CALL
Ventas
VTR
$47.5B
$7.36M 0.35%
150,000
VTR icon
57
PUT
Ventas
VTR
$47.5B
$7.36M 0.35%
150,000
ROCC
58
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$7.31M 0.35%
720,000
-164,603
-19% -$1.55M
UCO icon
59
PUT
ProShares Ultra Bloomberg Crude Oil
UCO
$368M
$7.25M 0.34%
800,000
ERII icon
60
Energy Recovery
ERII
$457M
$7.09M 0.34%
520,000
CRESY
61
Cresud
CRESY
$784M
$6.61M 0.31%
1,435,363
EUCRU
62
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$6.4M 0.3%
+600,000
New +$6.09M
INSE icon
63
Inspired Entertainment
INSE
$185M
$6.38M 0.3%
969,081
+152,756
+19% +$818K
OTIC
64
DELISTED
Otonomy, Inc.
OTIC
$6.21M 0.29%
960,054
+60,054
+7% +$273K
CLLS
65
Cellectis
CLLS
$281M
$5.83M 0.28%
215,386
+15,386
+8% +$345K
APTO
66
DELISTED
Aptose Biosciences, Inc.
APTO
$5.11M 0.24%
2,593
CMBT
67
CMB.TECH NV
CMBT
$4.62B
$5.1M 0.24%
637,000
+365,000
+134% +$2.98M
LRMR icon
68
Larimar Therapeutics
LRMR
$426M
$4.71M 0.22%
220,136
IOVA icon
69
Iovance Biotherapeutics
IOVA
$1.94B
$4.64M 0.22%
100,000
IRCP
70
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$4.52M 0.21%
2,118,220
+262,072
+14% +$562K
IRS
71
IRSA Inversiones y Representaciones
IRS
$1.26B
$4.49M 0.21%
953,130
+5,314
+0.6% +$22.2K
JPM icon
72
JPMorgan Chase
JPM
$955B
$4.45M 0.21%
35,000
NAUT icon
73
Nautilus Biotechnolgy
NAUT
$118M
$4.34M 0.21%
400,000
ATRA icon
74
Atara Biotherapeutics
ATRA
$76.9M
$4.33M 0.21%
8,834
GSAT icon
75
Globalstar
GSAT
$10.7B
$4.01M 0.19%
789,256

Similar funds

683 Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, 683 Capital Management held 236 positions worth $2.11B, up 55% from $1.37B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

683 Capital Management deployed $251M of net new capital in Q4 2020, opening 91 new positions and adding to 31 existing holdings. Its largest new stake was QuantumScape Corporation Warrants, each whole warrant exercisable for one share of Class A common st: 932,417 shares worth $35.4M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Cardlytics, an estimated $36.3M trimmed.

  • 683 Capital Management's largest Q4 2020 buy was QuantumScape Corporation Warrants, each whole warrant exercisable for one share of Class A common st: 932,417 shares worth $35.4M.
  • 683 Capital Management added most to FirstEnergy in Q4 2020, an estimated $35.4M increase.
  • 683 Capital Management's biggest Q4 2020 reduction was Cardlytics, cutting an estimated $36.3M.
  • 683 Capital Management fully exited On Deck Capital, Inc. in Q4 2020, selling an estimated $9.27M.
  • 683 Capital Management's ten largest holdings make up 49% of its $2.11B portfolio in Q4 2020.
  • 683 Capital Management opened 91 new positions and closed 27 in Q4 2020.
  • 683 Capital Management's portfolio value rose 55% quarter-over-quarter to $2.11B.

Based on 683 Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.